Literature DB >> 25843756

"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs.

Francesco Martinelli1, Anna Giulia Balducci2, Alessandra Rossi1, Fabio Sonvico1, Paolo Colombo1, Francesca Buttini3.   

Abstract

In this work three capsule-based dry powder inhalers, available for generics product development, were compared. Two technologically different dry powder formulations were used in order to relate the capsule piercing position and motion in the device to their aerodynamic performance. A "pierce and inhale" design, in which the capsules pierced with RS01, HandiHaler or Turbospin devices were aerosolized in the same device or transferred and aerosolized with another device, was constructed and carried out. The results obtained showed that two dry powder formulations, i.e., a drug/lactose blend or a carrier-free powder, aerosolized using capsule based inhalers, performed differently. The aerosolization of drug carrier mixture in terms of drug dispersion and emitted dose, was more sensible to the piercing and device combination than the carrier free powder. The motion of the capsule during the aerosolization boosted the powder emission, whereas the powder disaggregation was more influenced by the airflow pattern around the capsule and inside the inhaler turbulence chamber.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Capsule motion; Dry powder inhaler; Formoterol fumarate; HandiHaler; RS01; Spray-dried insulin; Turbospin

Mesh:

Substances:

Year:  2015        PMID: 25843756     DOI: 10.1016/j.ijpharm.2015.04.003

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy.

Authors:  Eleonora Maretti; Luca Costantino; Francesca Buttini; Cecilia Rustichelli; Eliana Leo; Eleonora Truzzi; Valentina Iannuccelli
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

2.  Responsive Hydrogel Nanoparticles for Pulmonary Delivery.

Authors:  Nathanael A Stocke; Susanne M Arnold; J Zach Hilt
Journal:  J Drug Deliv Sci Technol       Date:  2015-10-01       Impact factor: 3.981

Review 3.  Flow and Particle Modelling of Dry Powder Inhalers: Methodologies, Recent Development and Emerging Applications.

Authors:  Zhanying Zheng; Sharon Shui Yee Leung; Raghvendra Gupta
Journal:  Pharmaceutics       Date:  2021-02-01       Impact factor: 6.321

4.  State of the Art in Capsule-Based Dry Powder Inhalers: Deagglomeration Techniques and the Consequences for Formulation Aerosolization.

Authors:  Roman Groß; Kai Berkenfeld; Christoph Schulte; Anselm Ebert; Sunita Sule; Ameet Sule; Alf Lamprecht
Journal:  Pharmaceutics       Date:  2022-05-31       Impact factor: 6.525

5.  Stability and In Vitro Aerodynamic Studies of Inhalation Powders Containing Ciprofloxacin Hydrochloride Applying Different DPI Capsule Types.

Authors:  Edit Benke; Patrícia Varga; Piroska Szabó-Révész; Rita Ambrus
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

6.  Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler.

Authors:  Francesca Buttini; Irene Pasquali; Gaetano Brambilla; Diego Copelli; Massimiliano Dagli Alberi; Anna Giulia Balducci; Ruggero Bettini; Viviana Sisti
Journal:  Pharm Res       Date:  2015-11-16       Impact factor: 4.200

7.  Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections.

Authors:  Irene Rossi; Francesca Buttini; Fabio Sonvico; Filippo Affaticati; Francesco Martinelli; Giannamaria Annunziato; Diana Machado; Miguel Viveiros; Marco Pieroni; Ruggero Bettini
Journal:  Pharmaceutics       Date:  2019-05-01       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.